| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 493.68B | 421.60B | 360.31B | 314.32B | 299.52B |
| Gross Profit | 243.18B | 198.92B | 160.04B | 122.39B | 134.84B |
| EBITDA | 177.77B | 132.99B | 106.62B | 71.72B | 93.93B |
| Net Income | 100.01B | 74.69B | 59.17B | 34.90B | 54.81B |
Balance Sheet | |||||
| Total Assets | 748.76B | 665.04B | 605.85B | 547.22B | 528.61B |
| Cash, Cash Equivalents and Short-Term Investments | 327.56B | 294.22B | 273.75B | 219.26B | 250.71B |
| Total Debt | 39.94B | 81.75B | 87.28B | 89.46B | 100.35B |
| Total Liabilities | 184.21B | 183.17B | 178.47B | 170.94B | 180.54B |
| Stockholders Equity | 564.54B | 481.85B | 427.36B | 376.26B | 348.06B |
Cash Flow | |||||
| Free Cash Flow | 79.98B | 47.76B | 73.75B | -7.68B | 73.41B |
| Operating Cash Flow | 135.66B | 114.62B | 103.06B | 36.10B | 96.54B |
| Investing Cash Flow | -55.32B | -67.89B | -29.22B | -42.79B | -22.99B |
| Financing Cash Flow | -51.90B | -25.78B | -24.20B | -27.47B | -27.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥1.76T | 10.12 | 8.89% | 0.78% | 13.65% | 2.51% | |
71 Outperform | ¥8.35T | 38.98 | 13.46% | 1.17% | 98.56% | 52.21% | |
70 Outperform | ¥2.66T | 25.53 | 17.57% | 0.84% | 17.10% | 33.90% | |
65 Neutral | ¥1.33T | 22.30 | 26.91% | 1.17% | 15.19% | 12.65% | |
63 Neutral | ¥984.46B | 56.32 | 6.70% | 1.80% | -8.27% | 21.14% | |
61 Neutral | ¥475.84B | 11.51 | -3.66% | 2.12% | 13.66% | -113.12% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |